ARCH Venture Partners VII, L.P. is 10% Owner at Syros Pharmaceuticals, Inc. (SYRS). They have made 3 open-market trades across 2 companies since 2016, most recently 2019-07-17.
CIK 0001544444
1 open-market purchase totalling $5.0M since 2016, against 2 sales. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.